Exsulin Corporation
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults (NCT00995540) | Exsulin Corporation | 2009-11-01 |
| Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes (NCT00071409) | Exsulin Corporation | 2003-10-01 |
| Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes (NCT00071422) | Exsulin Corporation | 2003-10-01 |
Track Exsulin Corporation automatically
Every clearance here is in the API, with alerts when new ones post.